gonadorelin

戈那瑞林

Report date: 2026/03/30 17:02:26

Base Information

Drug Namegonadorelin
Drug Alias NameGlp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2黄体激素释放激素(pyroglutamic acid)-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH25’一氧代脯氨酰-L-组氨酰-L-色氨酰-L-丝氨酰-L-酪氨酰-甘氯酰-L-精氨酰-L-精氨酰-L-脯氨酰-甘氨酰胺luteinizing hormone-releasing hormone isoform I +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone modulators
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsHypothalamic Diseases
Global Approved IndicationsHypothalamic Diseases
Approved Indications in ChinaHypothalamic Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMaanshan Fengyuan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMaanshan Fengyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypothalamic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeH01CA01V04CM01
Related LinksWikipediaDrugBankKEGG